APA (7th ed.) Citation

Wang, L., Zheng, G., Hu, Y., Maolan, A., Luo, Y., Li, Y., & Liu, R. Comparative efficacy and safety of first-line neoadjuvant therapy for early-stage non-small cell lung cancer based on immune checkpoint inhibitor therapy: A systematic review and network meta-analysis. BMC.

Chicago Style (17th ed.) Citation

Wang, Linfeng, Guangda Zheng, Yue Hu, Ayidana Maolan, Yue Luo, Yue Li, and Rui Liu. Comparative Efficacy and Safety of First-line Neoadjuvant Therapy for Early-stage Non-small Cell Lung Cancer Based on Immune Checkpoint Inhibitor Therapy: A Systematic Review and Network Meta-analysis. BMC.

MLA (9th ed.) Citation

Wang, Linfeng, et al. Comparative Efficacy and Safety of First-line Neoadjuvant Therapy for Early-stage Non-small Cell Lung Cancer Based on Immune Checkpoint Inhibitor Therapy: A Systematic Review and Network Meta-analysis. BMC.